この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2011/9/271 分で読めます
Guidance for Industry on User Fee Waivers, Reductions, and Refunds for Drug and Biological Products; Availability
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "User Fee Waivers, Reductions, and Refunds for Drug and Biological Products." This guidance provides recommendations to applicants considering whether to request a waiver or reduction in user fees. This guidance is a revision of the draft guidance entitled "Draft Interim Guidance Document for Waivers of and Reductions in User Fees," issued July 16, 1993.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →